Vaginosis, Bacterial Clinical Trial
Official title:
Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial
Bacterial Vaginosis (BV) is a infectious process of the female genitourinary tract, an important health issue due to the high incidence and high rate of recurrence of the infection. Therefore, new therapeutic modalities are sought with the capacity to minimize drug side effects and reduce cases of recurrence of the disease. The objective of this study is to evaluate the clinical and microbiological response of the 401+/- 5nm blue light emitting diode (LED) in the treatment of women with bacterial vaginosis. The group of women with diagnosis of bacterial vaginosis will be submitted to the light therapy. These women will also be submitted to an evaluation and examination by a ginecologist before and after the therapy. There will also be an evaluation of the clinical condition and about the effects of the light through the questionnaire answered before and after participant's treatment. It's expected that the 41 +/- 5nm LED will destroy the VB demonstrated by laboratory examination and also improves the signs and results analyzed by the gynecologist and participants.
A current treatment proposal is the use of blue LED of 401 +/- 5 nm wich is a light that has antimicrobial effect when exposed to endogenous porphyrin of the pathogens. This exposition produces reactive oxygen and it causes cells death with no possibilities of resistance by the bacterium. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT02558179 -
Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method
|
N/A | |
| Completed |
NCT02272231 -
Pathogenesis of Bacterial Vaginosis in Women Who Have Sex With Women
|
||
| Completed |
NCT02314429 -
Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis
|
Phase 1 | |
| Completed |
NCT02139839 -
Exploratory Study to Evaluate the Effects of the Probiotics L. Rhamnosus GR-1 and L. Reuteri RC-14
|
Phase 0 | |
| Recruiting |
NCT01448291 -
Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers
|
Phase 4 | |
| Completed |
NCT00153517 -
Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy
|
Phase 2 | |
| Completed |
NCT04989543 -
Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)
|
N/A | |
| Completed |
NCT02641717 -
Validity of Patient-Collected Wet Mounts
|
N/A | |
| Terminated |
NCT03943823 -
Postmenopausal Pessary Users: Estrogen Versus Trimosan
|
Phase 4 | |
| Completed |
NCT03134924 -
Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention "WASH-2"
|
N/A | |
| Completed |
NCT01293643 -
A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)
|
Phase 3 | |
| Terminated |
NCT01153958 -
Colposeptine for the Treatment of Bacterial Vaginosis
|
Phase 4 | |
| Completed |
NCT00484653 -
Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman
|
N/A | |
| Completed |
NCT05649735 -
EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS
|
N/A | |
| Completed |
NCT02860845 -
Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections
|
Phase 4 | |
| Not yet recruiting |
NCT00491270 -
Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery
|
Phase 3 | |
| Completed |
NCT01055106 -
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
|
Phase 2 | |
| Terminated |
NCT01322971 -
Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
|
N/A | |
| Completed |
NCT04171947 -
Vaginal Ovule With Flavonoid Tea Extract for the Correction of Imbalance in the Vaginal Environment
|
N/A | |
| Completed |
NCT02392026 -
Safety and Tolerability of Metronidazole Gel 1.3%
|
Phase 4 |